Skip to main content
A
A
<none>
Partner Agency Portal Login
Referrals Gateway
Secondary Menu
About Us
Careers
Partner Agencies
Publications
Contact Us
Search
Main navigation
Prosecution Process
Prosecution Policy
Steps in Prosecution
Key Legislation
Criminal Confiscation
How we Differ from State DPPs
Legal speak explained
Crimes We Prosecute
Fraud
General Fraud
Project Wickenby
Serious Financial Crime Taskforce
Social Security Fraud
Tax Fraud
Commercial
Money Laundering
Serious Drugs
Drug Manufacture
Drug Possession
Drug Trafficking, Selling and Cultivation
Importing and Exporting Drugs or Precursors
Illicit Tobacco Taskforce
People Smuggling
Human Trafficking and Slavery
Child Exploitation
Counter-Terrorism
Cybercrime
Cyberbullying and Threats
Environment
Safety
General Prosecutions
Case Reports
Fraud and Specialist Agencies
Human Exploitation and Border Protection
Organised Crime and National Security
Serious Financial and Corporate Crime
Prosecution Statistics
Statutory Function Statistics
Prosecution Performance Indicators
Prosecution Statistics
Victims and Witnesses
Victims of Crime Policy
Legal Speak Explained
Counsel
CDPP Counsel List EOI
Counsel Fee FAQs
Breadcrumb
Home
Publications and Policies
Medifraud prosecutions – unrepresented defendants [PGI RBF 2]
Publications and Policies
Publication Type
- Any -
Annual Reports
Budgets
Guidelines and Directions
National Legal Directions
Other
Policies
Practice Group Instructions
Submissions to Parliamentary Inquiries
Victims and Witnesses
Year of publication
Min
Max
Medifraud prosecutions – unrepresented defendants [PGI RBF 2]
17 November 2014
Attachment
Size
Download PDF
103.78 KB
Download RTF
1.77 MB
